Vitamin B can protect old people against Alzheimer's

The intake of vitamin B could protect a lot of old people, according
to a study in Alzheimer's disease. This is intended to slow the
age-related nämlöich brain atrophy.

The administration of vitamin B could in the elderly with mild
cognitive impairment (MCI), which reduces their memory, slow down the
natural age-related brain atrophy, pharmacologist at Oxford University
reported in a Thursday on the website of the Public Library of Science
One (PLOS One) published study. Thus, the development of Alzheimer's
disease and other forms of dementia could be delayed. MCI may be a
precursor of Alzheimer's.

The British researchers had studied 168 people over 70 diagnosed with
mild cognitive impairment. Half the subjects received two years of
high doses of folic acid, vitamin B6 and vitamin B12, the comparison
group received a placebo. In the patients who took the vitamin B,
slowed, according to the scientists of the brain-wasting on average by
30 percent, with some even by 53 percent.
Protective effect of brain structure

"We hope that this simple and safe treatment of developing
Alzheimer's disease may slow in many people who suffer from mild
cognitive impairment," the scientists involved in the study, David
Smith. The prescribed vitamins have on brain structure and a
protective effect against Alzheimer's by bending. Further studies
still need to show whether vitamin B on the slowing of brain shrinkage
also actually works against Alzheimer's. About 37 million people
worldwide suffer from dementia, most of them caused by Alzheimer's
disease.

Vitamin B comes naturally in many foods such as meat, eggs, fish and
green vegetables. Too high a dose of the drug can cause undesirable
side effects.

Just a few months - in April - in the U.S. medical journal JAMA
published a large study from France, according to suffer through the
Ginkgo extract EGb 761 in revenue for a period of at least four years
away, the risk of developing Alzheimer's disease, could reduce by
nearly half. It had been a case study of nearly 3,100 people aged
72-96 years, of which one half was given twice daily 120 mg of extract
or a placebo.

The efficacy of Ginkgo biloba extract has been discussed for some
time in the professional world. The Viennese specialist Peter
Dal-Bianco said, among other things. "Currently based the study
location to Ginkgo biloba on studies that do not meet the requirements
of regulatory agencies fully the evidence (notes, note) for
significant therapeutic effects of Ginkgo biloba in dementia patients,
despite presence of some negative studies overwhelmingly positive. "